It has been found that some NSCLC lines (H2228 and DFCI032, but not H3122) withoncogenic activa tion of ALK express low E-cadherin levels and high levels ofvimentin and other mesenchymal markers. The gene discussed is CDH1; the disease is non-small cell lung carcinoma.